Clinical Trial Update: MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two chemotherapy regimens for ovarian cancer; results not yet available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Carboplatin/Liposomal Doxorubicin
• carboplatin/paclitaxel

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Ovarian Cancer | Phase 3 | Status: UNKNOWN